Source: ALL
Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs6912013
rs6912013
Entrez Id: 4800;221443
Gene Symbol: NFYA;OARD1
NFYA;OARD1
CUI: C0023467
Disease:
Leukemia, Myelocytic, Acute 		T 0.700 GeneticVariation GWASCAT Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia. 27903959 2017
dbSNP: rs7760860
rs7760860
Entrez Id: 4800;221443
Gene Symbol: NFYA;OARD1
NFYA;OARD1
CUI: C0023467
Disease:
Leukemia, Myelocytic, Acute 		T 0.700 GeneticVariation GWASCAT Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia. 27903959 2017
dbSNP: rs9296355
rs9296355
Entrez Id: 4800;221443
Gene Symbol: NFYA;OARD1
NFYA;OARD1
CUI: C0023467
Disease:
Leukemia, Myelocytic, Acute 		C 0.700 GeneticVariation GWASCAT Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia. 27903959 2017
dbSNP: rs9296355
rs9296355
Entrez Id: 4800;221443
Gene Symbol: NFYA;OARD1
NFYA;OARD1
CUI: C0023467
Disease:
Leukemia, Myelocytic, Acute 		T 0.700 GeneticVariation GWASCAT Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia. 27903959 2017
dbSNP: rs35163651
rs35163651
Entrez Id: 4800;221443
Gene Symbol: NFYA;OARD1
NFYA;OARD1
CUI: C0023508
Disease:
White Blood Cell Count procedure 		GT 0.700 GeneticVariation GWASCAT The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease. 27863252 2016
dbSNP: rs2268188
rs2268188
Entrez Id: 4800;221443
Gene Symbol: NFYA;OARD1
NFYA;OARD1
CUI: C0011860
Disease:
Diabetes Mellitus, Non-Insulin-Dependent 		0.010 GeneticVariation BEFREE Haplotype analysis showed that SNPs rs2268188, rs6918969, rs28869187, and rs35105472 formed a haplotype block, and haplotype TTAC was protective against T2DM (OR = 0.76, 95% CI = 0.33-0.82, <i>P</i> = 0.004), while haplotype GCCG was associated with an elevated susceptibility to T2DM (OR = 2.33, 95% CI = 1.43-3.57, <i>P</i> = 0.001). 31205951 2019
dbSNP: rs28869187
rs28869187
Entrez Id: 4800;221443
Gene Symbol: NFYA;OARD1
NFYA;OARD1
CUI: C0011860
Disease:
Diabetes Mellitus, Non-Insulin-Dependent 		0.010 GeneticVariation BEFREE Of the five tagSNPs, we found that three SNPs (rs2268188, rs6918969, and rs28869187) exhibited nominal significant differences in allelic or genotypic frequency between patients with T2DM and healthy individuals. 31205951 2019
dbSNP: rs35105472
rs35105472
Entrez Id: 4800;221443
Gene Symbol: NFYA;OARD1
NFYA;OARD1
CUI: C0011860
Disease:
Diabetes Mellitus, Non-Insulin-Dependent 		0.010 GeneticVariation BEFREE Haplotype analysis showed that SNPs rs2268188, rs6918969, rs28869187, and rs35105472 formed a haplotype block, and haplotype TTAC was protective against T2DM (OR = 0.76, 95% CI = 0.33-0.82, <i>P</i> = 0.004), while haplotype GCCG was associated with an elevated susceptibility to T2DM (OR = 2.33, 95% CI = 1.43-3.57, <i>P</i> = 0.001). 31205951 2019
dbSNP: rs6918969
rs6918969
Entrez Id: 4800;221443
Gene Symbol: NFYA;OARD1
NFYA;OARD1
CUI: C0011860
Disease:
Diabetes Mellitus, Non-Insulin-Dependent 		0.010 GeneticVariation BEFREE The minor alleles G, C, and C at rs2268188, rs6918969</span>, and rs28869187, respectively, conferred a higher T2DM risk under a dominant genetic model, and the carriers of these risk alleles (either homozygotes of the minor allele or heterozygotes) had statistically higher levels of fasting plasma glucose, cholesterol, and triglycerides. 31205951 2019